ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 111 filers reported holding ALBIREO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $281,989 | +944.4% | 13,049 | +837.4% | 0.00% | – |
| Q3 2022 | $27,000 | +92.9% | 1,392 | +100.6% | 0.00% | – |
| Q2 2022 | $14,000 | -48.1% | 694 | -24.1% | 0.00% | – |
| Q1 2022 | $27,000 | -74.5% | 914 | -79.9% | 0.00% | – |
| Q4 2021 | $106,000 | -91.9% | 4,555 | -89.2% | 0.00% | – |
| Q3 2021 | $1,312,000 | -88.4% | 42,050 | -86.9% | 0.00% | -100.0% |
| Q2 2021 | $11,270,000 | -0.2% | 320,350 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $11,292,000 | -23.5% | 320,350 | -18.6% | 0.00% | 0.0% |
| Q4 2020 | $14,758,000 | +1.5% | 393,450 | -9.7% | 0.00% | 0.0% |
| Q3 2020 | $14,538,000 | +132.9% | 435,650 | +84.9% | 0.00% | 0.0% |
| Q2 2020 | $6,242,000 | +38.2% | 235,650 | -14.6% | 0.00% | 0.0% |
| Q1 2020 | $4,516,000 | -57.7% | 275,900 | -34.3% | 0.00% | 0.0% |
| Q4 2019 | $10,679,000 | +27.1% | 420,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $8,402,000 | -38.0% | 420,100 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $13,544,000 | +0.1% | 420,100 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $13,531,000 | +14.7% | 420,100 | -12.7% | 0.00% | 0.0% |
| Q4 2018 | $11,799,000 | -25.6% | 481,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $15,854,000 | -28.9% | 481,000 | -23.4% | 0.00% | -33.3% |
| Q2 2018 | $22,284,000 | +9.0% | 627,732 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $20,445,000 | – | 627,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |